Kimberly Collins
Senior Quantitative Medicine Scientist, Critical Path Institute
About this speaker
Kimberly Collins is a Senior Quantitative Medicine Scientist in Pharmacometrics at the Critical Path Institute with an adjunct appointment in the Department of Medicine at Indiana University School of Medicine. She earned her PhD and completed a post-doctoral fellowship program at Indiana University School of Medicine. Her current research is focused on reducing trial duration in prevention and new-onset Type 1 diabetes by identifying individuals that will most likely benefit from potential therapies.
